Center for Scientific Review; Notice of Closed Meetings, 5219-5220 [2020-01491]

Download as PDF Federal Register / Vol. 85, No. 19 / Wednesday, January 29, 2020 / Notices Dated: January 23, 2020. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–01496 Filed 1–28–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meetings lotter on DSKBCFDHB2PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Heart, Lung, and Blood Initial Review Group; Single-Site and Pilot Clinical Trials Review Committee. Date: March 4–5, 2020. Time: 8:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, Montgomery County Conference Center Facility, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Carol (Chang-Sook) Kim, Ph.D., Scientific Review Administrator, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7188, Bethesda, MD 20892–7924, 301–827–7940, carolko@ mail.nih.gov. Name of Committee: Heart, Lung, and Blood Initial Review Group; NHLBI Mentored Transition to Independence Review Committee. Date: March 5–6, 2020. Time: 8:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: The William F. Bolger Center, 9600 Newbridge Drive, Potomac, MD 20854. Contact Person: Giuseppe Pintucci, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7192, Bethesda, MD 20892, 301–435–0287, Pintuccig@nhlbi.nih.gov. Name of Committee: Heart, Lung, and Blood Initial Review Group; NHLBI Mentored Clinical and Basic Science Review. Date: March 19–20, 2020. Time: 10:30 a.m. to 3:00 p.m. VerDate Sep<11>2014 17:27 Jan 28, 2020 Jkt 250001 Agenda: To review and evaluate grant applications. Place: Holiday Inn National Airport Hotel, 2650 Jefferson Davis Highway, Arlington, VA 22202. Contact Person: Keith A. Mintzer, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7186, Bethesda, MD 20892–7924, 301–827– 7949, mintzerk@nhlbi.nih.gov. Name of Committee: Heart, Lung, and Blood Initial Review Group; Heart, Lung, and Blood Program Project Review. Date: March 20, 2020. Time: 8:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: Sheraton BWI (Baltimore), 1100 Old Elkridge Landing Road, Baltimore, MD 21090. Contact Person: Jeffrey H. Hurst, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Room 7208, Bethesda, MD 20892, 301–435–0303, hurstj@ nhlbi.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: January 23, 2020. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–01493 Filed 1–28–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 5219 Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel; Brain Initiative RFA (EB–19–001; EB–19–002) Review SEP. Date: February 19, 2020. Time: 9:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: John K. Hayes, Ph.D., Scientific Review Officer, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 6707 Democracy Blvd., Suite 959, Bethesda, MD 20892, (301) 496–8775, hayesj@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, HHS) Dated: January 23, 2020. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–01495 Filed 1–28–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Vascular and Hematology Integrated Review Group; Hypertension and Microcirculation Study Section—Hypertension and Microcirculation. Date: February 19–20, 2020. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: New Orleans Marriott, 555 Canal Street, New Orleans, LA 70130. Contact Person: Bukhtiar H. Shah, DVM, Ph.D., Scientific Review Officer, Vascular and Hematology IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4120, MSC 7802, Bethesda, MD 20892, (301) 806–7314, shahb@csr.nih.gov. E:\FR\FM\29JAN1.SGM 29JAN1 lotter on DSKBCFDHB2PROD with NOTICES 5220 Federal Register / Vol. 85, No. 19 / Wednesday, January 29, 2020 / Notices Name of Committee: Risk, Prevention and Health Behavior Integrated Review Group; Addiction Risks and Mechanisms Study Section. Date: February 24–25, 2020. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Hotel Solamar, 435 6th Avenue, San Diego, CA 92101. Contact Person: Kristen Prentice, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3112, MSC 7808, Bethesda, MD 20892, (301) 496– 0726, prenticekj@mail.nih.gov. Name of Committee: Oncology 2— Translational Clinical Integrated Review Group; Mechanisms of Cancer Therapeutics—2 Study Section. Date: February 24–25, 2020. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW, Washington, DC 20015. Contact Person: Careen K. Tang-Toth, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6214, MSC 7804, Bethesda, MD 20892, (301) 435– 3504, tothct@csr.nih.gov. Name of Committee: Oncology 2— Translational Clinical Integrated Review Group; Drug Discovery and Molecular Pharmacology Study Section. Date: February 24–25, 2020. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Jeffrey Smiley, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6194, MSC 7804, Bethesda, MD 20892, 301–594– 7945, smileyja@csr.nih.gov. Name of Committee: Genes, Genomes, and Genetics Integrated Review Group; Genetics of Health and Disease Study Section. Date: February 24–25, 2020. Time: 8:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. Contact Person: Christopher Payne, Ph.D., Scientific Review Officer, Center for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 20892, 301–402–3702, christopher.payne@nih.gov. Name of Committee: Oncology 2— Translational Clinical Integrated Review Group; Clinical Oncology Study Section. Date: February 24, 2020. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Ritz-Carlton Hotel, 1700 Tysons Boulevard, McLean, VA 22102. Contact Person: Malaya Chatterjee, Ph.D., Scientific Review Officer, Center for VerDate Sep<11>2014 17:27 Jan 28, 2020 Jkt 250001 Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6192, MSC 7804, Bethesda, MD 20892, 301–806– 2515, chatterm@csr.nih.gov. Name of Committee: Cell Biology Integrated Review Group; Biology of the Visual System Study Section. Date: February 24–25, 2020. Time: 8:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Michael H. Chaitin, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5202, MSC 7850, Bethesda, MD 20892, (301) 435– 0910, chaitinm@csr.nih.gov. Name of Committee: Biobehavioral and Behavioral Processes Integrated Review Group; Child Psychopathology and Developmental Disabilities Study Section. Date: February 24–25, 2020. Time: 8:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Fairmont in Washington DC, 2401 M Street NW, Washington, DC 20037. Contact Person: Katherine Colona Morasch, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3170, Bethesda, MD 20892, (301) 594–9147, moraschkc@csr.nih.gov. Name of Committee: Healthcare Delivery and Methodologies Integrated Review Group; Community-Level Health Promotion Study Section. Date: February 24–25, 2020. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Wyndham San Antonio River Walk, 111 East Pecan Street, San Antonio, TX 78205. Contact Person: Ping Wu, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3166, Bethesda, MD 20892, 301– 451–8428, wup4@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: January 23, 2020. Tyeshia M. Roberson, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–01491 Filed 1–28–20; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Notice To Announce Request for Information To Assist in the Development of a New Strategic Plan for the National Institute on Deafness and Other Communication Disorders, for 2022–2026 AGENCY: National Institutes of Health, HHS. ACTION: Notice. The National Institute on Deafness and Other Communication Disorders (NIDCD) is in the process of developing a new Strategic Plan for 2022–2026 to help guide the research it supports over the next five years. Through this Request for Information, NIDCD invites researchers in academia and industry, health care professionals, patient advocates and health advocacy organizations, scientific or professional organizations, Federal agencies, and other interested members of the public to provide ideas to inform development of NIDCD’s next strategic plan. DATES: The NIDCD’s Request for Information is open for public idea submission for a period of 60 days. Ideas must be received by March 31, 2020, to ensure consideration. After the idea submission period has closed, NIDCD will consider the ideas we received in a timely manner for the development of the 2022–2026 Strategic Plan of the National Institute on Deafness and Other Communication Disorders. SUMMARY: Please visit our website to view our questions and submit your ideas to NIDCD electronically: https:// www.nidcd.nih.gov/about/strategicplan/2022-2026/2022-2026-nidcdstrategic-planning-process. NIDCD will also accept submissions via email (NIDCDStrategicPlan@nidcd.nih.gov). FOR FURTHER INFORMATION CONTACT: Laura K. Cole, Ph.D., Planning and Evaluation Officer, Science Policy and Planning Branch, National Institute on Deafness and Other Communication Disorders, NIH, 31 Center Drive, Suite 3C25, Bethesda, MD 20892. Phone: 301– 402–2313. Email: colel@nidcd.nih.gov. SUPPLEMENTARY INFORMATION: This notice is in accordance with the 21st Century Cures Act, NIH institutes are required to regularly update their strategic plans. The NIDCD’s mission is to improve the lives of the millions of people with hearing loss and other communication disorders, spanning functions of hearing, balance, taste, ADDRESSES: E:\FR\FM\29JAN1.SGM 29JAN1

Agencies

[Federal Register Volume 85, Number 19 (Wednesday, January 29, 2020)]
[Notices]
[Pages 5219-5220]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01491]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Vascular and Hematology Integrated Review 
Group; Hypertension and Microcirculation Study Section--Hypertension 
and Microcirculation.
    Date: February 19-20, 2020.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: New Orleans Marriott, 555 Canal Street, New Orleans, LA 
70130.
    Contact Person: Bukhtiar H. Shah, DVM, Ph.D., Scientific Review 
Officer, Vascular and Hematology IRG, Center for Scientific Review, 
National Institutes of Health, 6701 Rockledge Drive, Room 4120, MSC 
7802, Bethesda, MD 20892, (301) 806-7314, [email protected].


[[Page 5220]]


    Name of Committee: Risk, Prevention and Health Behavior 
Integrated Review Group; Addiction Risks and Mechanisms Study 
Section.
    Date: February 24-25, 2020.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hotel Solamar, 435 6th Avenue, San Diego, CA 92101.
    Contact Person: Kristen Prentice, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3112, MSC 7808, Bethesda, MD 
20892, (301) 496-0726, [email protected].

    Name of Committee: Oncology 2--Translational Clinical Integrated 
Review Group; Mechanisms of Cancer Therapeutics--2 Study Section.
    Date: February 24-25, 2020.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road NW, Washington, DC 20015.
    Contact Person: Careen K. Tang-Toth, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6214, MSC 7804, Bethesda, MD 
20892, (301) 435-3504, [email protected].

    Name of Committee: Oncology 2--Translational Clinical Integrated 
Review Group; Drug Discovery and Molecular Pharmacology Study 
Section.
    Date: February 24-25, 2020.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Jeffrey Smiley, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6194, MSC 7804, Bethesda, MD 
20892, 301-594-7945, [email protected].

    Name of Committee: Genes, Genomes, and Genetics Integrated 
Review Group; Genetics of Health and Disease Study Section.
    Date: February 24-25, 2020.
    Time: 8:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892.
    Contact Person: Christopher Payne, Ph.D., Scientific Review 
Officer, Center for Scientific Review, 6701 Rockledge Drive, 
Bethesda, MD 20892, 301-402-3702, [email protected].

    Name of Committee: Oncology 2--Translational Clinical Integrated 
Review Group; Clinical Oncology Study Section.
    Date: February 24, 2020.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton Hotel, 1700 Tysons Boulevard, McLean, VA 
22102.
    Contact Person: Malaya Chatterjee, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6192, MSC 7804, Bethesda, MD 
20892, 301-806-2515, [email protected].

    Name of Committee: Cell Biology Integrated Review Group; Biology 
of the Visual System Study Section.
    Date: February 24-25, 2020.
    Time: 8:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Michael H. Chaitin, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5202, MSC 7850, Bethesda, MD 
20892, (301) 435-0910, [email protected].

    Name of Committee: Biobehavioral and Behavioral Processes 
Integrated Review Group; Child Psychopathology and Developmental 
Disabilities Study Section.
    Date: February 24-25, 2020.
    Time: 8:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Fairmont in Washington DC, 2401 M Street NW, Washington, 
DC 20037.
    Contact Person: Katherine Colona Morasch, Ph.D., Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3170, Bethesda, MD 20892, (301) 
594-9147, [email protected].

    Name of Committee: Healthcare Delivery and Methodologies 
Integrated Review Group; Community-Level Health Promotion Study 
Section.
    Date: February 24-25, 2020.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Wyndham San Antonio River Walk, 111 East Pecan Street, 
San Antonio, TX 78205.
    Contact Person: Ping Wu, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3166, Bethesda, MD 20892, 301-451-8428, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: January 23, 2020.
Tyeshia M. Roberson,
 Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-01491 Filed 1-28-20; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.